Blog

IBS-C Treatment Advances: Natural Products and Meal Timing in Focus Irritable bowel syndrome with constipation (IBS-C) is a complex disorder where chron…

SIBO and IBS Overlap: Rifaximin Leads in Efficacy with a 16.7% Adverse Event Rate A 2026 systematic review analyzed 55 studies to compare three antibiot…

A 2026 review from researchers at Heliopolis University and Cairo University provides a detailed map of the complex pathophysiology driving irritable bo…

SIBO IBS Overlap & Diagnosis: Why Symptoms Alone Fail The SIBO IBS Overlap: Diagnosis and Differentiation in an Era of Complex Overlap Clinical symptoms…

New reviews of irritable bowel syndrome with constipation (IBS-C) research point toward a deeper understanding of its causes

Rifaximin Efficacy in SIBO and IBS-D Backed by 55-Study Systematic Review A 2026 systematic review published in World J Methodol analyzed 55 clinical st…

Irritable bowel syndrome with constipation (IBS-C) is a complex condition where abdominal pain accompanies infrequent, difficult bowel movements

Rifaximin Leads in Efficacy for SIBO and IBS-D, But Recurrence Remains a Problem A 2026 systematic review analyzing 55 studies provides the clearest com…

Irritable bowel syndrome with constipation (IBS-C) is a complex condition where abdominal pain and infrequent, difficult bowel movements stem from a dys…

Rifaximin Shows 16.7% Adverse Event Rate in SIBO and IBS-D Review A systematic review of 55 studies published in World J Methodol in 2026 analyzed the r…

A Multifactorial Disorder: IBS-C is More Than Slow Transit Irritable bowel syndrome with constipation (IBS-C) is more than infrequent bowel movements

Research Shows Clinical Symptoms Cannot Tell SIBO and Sucrose Malabsorption Apart A 2026 study from gastroenterologists at Beth Israel Deaconess Medical…